๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2839060 77 M IA 04/30/2025 COVID19
COVID19
 MODERNA
MODERNA

Blood test, Fatigue, Flushing, Magnetic resonance imaging, Phantosmia; Skin disc... Blood test, Fatigue, Flushing, Magnetic resonance imaging, Phantosmia; Skin discomfort More
I was dealing with flushed head; I was dealing with skin sensation; I was dealing with extreme fatig... I was dealing with flushed head; I was dealing with skin sensation; I was dealing with extreme fatigue; I was smelling things (odors) that were not there. Initially like oil, then heavy chemical smells day and night/this time the phantom odor (Phantosmia); This spontaneous case was reported by a patient and describes the occurrence of FLUSHING (I was dealing with flushed head), SKIN DISCOMFORT (I was dealing with skin sensation), PAROSMIA (I was smelling things (odors) that were not there. Initially like oil, then heavy chemical smells day and night/this time the phantom odor (Phantosmia)) and FATIGUE (I was dealing with extreme fatigue) in a 77-year-old male patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. The patient's past medical history included Sickness (Patient became less sick, but still something, in January 2020. Before anyone knew what it was. so, it could have been covid). Previously administered products included for Product used for unknown indication: Unspecified vaccine (Luckily patient had not had any side effects on any other types of vaccines); for COVID-19 prophylaxis: Spikevax NOS (Patient started taking the Moderna version as soon as it became available and with no side effects.). Past adverse reactions to the above products included No adverse effect with Spikevax NOS and Unspecified vaccine. Family history included Polio (patient's mother had polio as a girl). In September 2024, the patient received eighth dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) dosage was changed to 1 dosage form. On an unknown date, the patient received ninth dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (unknown route) 1 dosage form. In 2024, the patient experienced PAROSMIA (I was smelling things (odors) that were not there. Initially like oil, then heavy chemical smells day and night/this time the phantom odor (Phantosmia)). In November 2024, the patient experienced FLUSHING (I was dealing with flushed head), SKIN DISCOMFORT (I was dealing with skin sensation) and FATIGUE (I was dealing with extreme fatigue). At the time of the report, FLUSHING (I was dealing with flushed head), SKIN DISCOMFORT (I was dealing with skin sensation), PAROSMIA (I was smelling things (odors) that were not there. Initially like oil, then heavy chemical smells day and night/this time the phantom odor (Phantosmia)) and FATIGUE (I was dealing with extreme fatigue) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2024, Blood test: Patient had a blood workup followed by ear/nose/throat. Finding nothing and the physicians basically shrugging their shoulders. On an unknown date, Magnetic resonance imaging: Finding nothing and the physicians basically shrugging their shoulders. No concomitant and treatment medication were reported. Patient had a question concerning the Moderna COVID vaccine. Patient was growing up in the 1950s, patient was 100% pro-vaccine. In Sep-2024, patient had 8th Moderna and within a couple of days, patient was smelling things (odors) that were not there. Initially like oil, then heavy chemical smells day and night. By Nov-2024, patient was dealing with extreme fatigue, flushed head and skin sensation. In Mar-2025 there was a slight improvement, patient got the booster, and all the symptoms had come back, in spades this time the phantom odor (Phantosmia) was like saline water. Patient thought he had not had Covid before. At his age, Patient had a big X on his back for covid, so patient did everything to avoid it. It was unknown if the patient experienced any additional symptoms/events. More
2839061 72 F 04/30/2025 COVID19
 MODERNA
 3043838
Fatigue, Injection site bruising, Injection site mass, Injection site pain, Urti... Fatigue, Injection site bruising, Injection site mass, Injection site pain, Urticaria More
she developed a hive (urticaria) on the right foot/has hives in the middle of the gluteal area; expe... she developed a hive (urticaria) on the right foot/has hives in the middle of the gluteal area; experienced fatigue; She also experienced pain at injection site along with a large hard lump and bruising at injection site; She also experienced pain at injection site along with a large hard lump and bruising at injection site; She also experienced pain at injection site along with a large hard lump and bruising at injection site; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE BRUISING (She also experienced pain at injection site along with a large hard lump and bruising at injection site), URTICARIA (she developed a hive (urticaria) on the right foot/has hives in the middle of the gluteal area), FATIGUE (experienced fatigue), INJECTION SITE PAIN (She also experienced pain at injection site along with a large hard lump and bruising at injection site) and INJECTION SITE MASS (She also experienced pain at injection site along with a large hard lump and bruising at injection site) in a 72-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3043838) for COVID-19 prophylaxis. The patient's past medical history included Skin cancer. Previously administered products included for Product used for unknown indication: Pfizer BioNTech COVID-19 vaccine (she has always taken Pfizer COVID vaccine before). Past adverse reactions to the above products included No adverse effect with Pfizer BioNTech COVID-19 vaccine. On 22-Apr-2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter. On 22-Apr-2025, the patient experienced INJECTION SITE BRUISING (She also experienced pain at injection site along with a large hard lump and bruising at injection site), FATIGUE (experienced fatigue), INJECTION SITE PAIN (She also experienced pain at injection site along with a large hard lump and bruising at injection site) and INJECTION SITE MASS (She also experienced pain at injection site along with a large hard lump and bruising at injection site). On 23-Apr-2025, the patient experienced URTICARIA (she developed a hive (urticaria) on the right foot/has hives in the middle of the gluteal area). At the time of the report, INJECTION SITE BRUISING (She also experienced pain at injection site along with a large hard lump and bruising at injection site), URTICARIA (she developed a hive (urticaria) on the right foot/has hives in the middle of the gluteal area), FATIGUE (experienced fatigue) and INJECTION SITE MASS (She also experienced pain at injection site along with a large hard lump and bruising at injection site) had not resolved and INJECTION SITE PAIN (She also experienced pain at injection site along with a large hard lump and bruising at injection site) had resolved. No concomitant medications were reported. It was reported that she was taking Moderna vaccine for the first time and always taken Pfizer vaccine before. On the day of vaccination, patient experienced fatigue and that lasted for 2 days. She also experienced pain at injection site along with a large hard lump and bruising at injection site. It was reported that 2 days after vaccine administration, the pain was gone but the bruising and lump still persist. On 23-Apr-2025, 19 hours after vaccination, she developed a hive (urticaria) on the right foot and on 24-Apr-2025, she also had hives in the middle of gluteal area. It was unknown if the patient experienced any additional symptoms or events. No treatment medications were reported. More
2839062 04/30/2025 COVID19
 UNKNOWN MANUFACTURER
Vaccination site pain, Wrong product administered Vaccination site pain, Wrong product administered
mild/grade one tenderness at the injection site; Administration error to study participant; This is ... mild/grade one tenderness at the injection site; Administration error to study participant; This is a spontaneous report received from a Physician and an Other HCP. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (BNT162B2 OMICRON (KP.2)), on 21Apr2025 as dose 1, 0.3 ml single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious) with onset 23Apr2025, outcome "unknown", described as "Administration error to study participant"; VACCINATION SITE PAIN (non-serious) with onset 23Apr2025, outcome "unknown", described as "mild/grade one tenderness at the injection site". Additional information: On 21Apr2025 a study participant was screened and randomized for an avian flu vaccination study. Study was prepared and ready for administration around the same time for participant (ID withheld), protocol. The drug was given to the study participant in the study in error. The site process, which occurred with this participant, is to prepare per pharmacy manual, label the syringe with the occluding label, participant/study label and place in an opaque box for transport to the exam room for administration. The participant was taken to the exam room and the unblinded team verify the participant's full name and date of birth with the participant and the unblinded study team verify enrollment number syringe label number with the subject chart prior to administration. The double verification of the syringe label enrollment number to the participant chart was done in the preparation area but verification of the syringe to the subject chart again in the exam room was missed. Beginning 22Apr2025, they had placed labels on the opaque box to write the study and participant enrollment number as an additional verification of the contents of the box. The unblinded team would verbally verify the participant enrollment number on the syringe with the chart once in the exam room, prior to administration. This would be done for all studies going forward and all unblinded staff had been retrained to this verification process. The participant, Pl, and the sponsors of both studies were immediately notified of the error. Site would follow the subject for safety purposes which included daily phone contact for 8 days following vaccine administration at least once per month for 6 months following IP administration to document any AEs. The site was awaiting further guidance from Pfizer regarding the participant follow up schedule. The participant did not report any AEs during the 30min post vaccine observation period. The participant was given a copy of the consent for the study IMP they received. Information in email body: Hello - please be advised that per the Clinical team guidance, this erroneous administration of study drug to a non-Pfizer study participant was being reported to Pfizer US Drug Safety. was a blinded study an only the unblinded team was copied on this email as reporter was reporting the unblinded IP assignment for their reference, below. Please note that this participant received only the Pfizer IP (BNT162b8 monovalent (Omicron KP.2) 100 mcg/mL Vial 0.3 mL) - no IP for the other sponsor study they were enrolled in was administered and no safety concerns/reactions had been reported to date. Reporter had attached NTF/summary from the PI/site for your reference. On 23Apr2025: Drug Safety, In follow up to the initial email below, the participant reported mild/grade one tenderness at the injection site and no other symptoms on 23Apr2025. Reporter had included the unblinded site pharmacist/site director on this email who reported this and would report any further safety follow up updates. On 24Apr2025: Please be advised that (patient ID withheld) did not experience the AE or the dosing error. The participant who did does not have an ID as patient was not enrolled in a Pfizer trial but rather another sponsor trial, but received our IP. Apologies for any confusion on this. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained. More
2839063 04/30/2025 COVID19
 PFIZER\BIONTECH
Expired product administered Expired product administered
administered an expired COVID-19 Comirnaty vaccine; This is a spontaneous report received from an Ot... administered an expired COVID-19 Comirnaty vaccine; This is a spontaneous report received from an Other HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EXPIRED PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "administered an expired COVID-19 Comirnaty vaccine". The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received. More
2839064 16 F MA 04/30/2025 COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 LN05888
LN05888
LN05888
LN05888
Brain fog, C-reactive protein increased, Cardiac monitoring, Chest pain, Complem... Brain fog, C-reactive protein increased, Cardiac monitoring, Chest pain, Complement factor C3 increased; Dizziness, Echocardiogram normal, Electrocardiogram abnormal, Exercise tolerance decreased, Fatigue; Headache, Insomnia, Nausea, Neurological symptom, Red blood cell sedimentation rate increased; Sinus tachycardia, Tachycardia More
COMIRNATY 2024-25(12Y UP) SYRG PFIZER US PHARM LN0588 , FLUCELVAX TRIVAL 2024-2025 SYR SEQIRUS, IN... COMIRNATY 2024-25(12Y UP) SYRG PFIZER US PHARM LN0588 , FLUCELVAX TRIVAL 2024-2025 SYR SEQIRUS, INC. Lot # 946621 48 hour onset of symptoms tachycardia, exercise intolerance, excessive fatigue, brain fog, insomnia, headache, nausea and dizziness. More
โœ“
2839065 1 M UT 04/30/2025 HIBV
MMR
VARCEL
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
 x017449
x008385
X021638
Herpes zoster, Rash; Herpes zoster, Rash; Herpes zoster, Rash Herpes zoster, Rash; Herpes zoster, Rash; Herpes zoster, Rash
Rash. That spread down the dermatome, Diagnosed by dermatology as singles. Given Acyclovir (parents ... Rash. That spread down the dermatome, Diagnosed by dermatology as singles. Given Acyclovir (parents believe). Rash is now resolved and did resolve after a few weeks. More
2839074 79 F CA 04/30/2025 RSV
 PFIZER\WYETH
Cough, Diarrhoea, Headache Cough, Diarrhoea, Headache
PT HAD DIARRHEA AFTER 2 DAYS OF VACCINATION. SHE ALSO HAD HEADACHE AND COUGHING. PT HAD DIARRHEA AFTER 2 DAYS OF VACCINATION. SHE ALSO HAD HEADACHE AND COUGHING.
2839075 75 F CA 04/30/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
 EW0150
EW0150
EW0150



EW0150
EW0150
EW0150
Asthenia, Fatigue; Fatigue; Balance disorder, Fatigue, Tremor; Asthenia, Fatigue... Asthenia, Fatigue; Fatigue; Balance disorder, Fatigue, Tremor; Asthenia, Fatigue; Fatigue; Balance disorder, Fatigue, Tremor; Asthenia, Fatigue; Fatigue; Balance disorder, Fatigue, Tremor More
Debilitatimg chronic fatigue, contnuing to worsen in 2025. Debilitatimg chronic fatigue, contnuing to worsen in 2025.
โœ“
2839076 25 F MS 04/30/2025 MENB
 PFIZER\WYETH
Erythema, Migraine, Pain in extremity Erythema, Migraine, Pain in extremity
Redness the size of my palm, very noticeable and arm getting more sore days later. Migraine yesterd... Redness the size of my palm, very noticeable and arm getting more sore days later. Migraine yesterday More
2839077 41 F TN 04/30/2025 COVID19
 MODERNA
Amnesia, Blood test, Cognitive disorder, Magnetic resonance imaging Amnesia, Blood test, Cognitive disorder, Magnetic resonance imaging
In July of 2024 I began having cognitive decline, with memory loss. In July of 2024 I began having cognitive decline, with memory loss.
โœ“
2839078 72 F CA 04/30/2025 COVID19
 MODERNA
 027A21A
Basal cell carcinoma, Invasive ductal breast carcinoma Basal cell carcinoma, Invasive ductal breast carcinoma
Breathing, basal cell carcinoma on my left cheek, and invasive ductal carcinoma, right breast cancer Breathing, basal cell carcinoma on my left cheek, and invasive ductal carcinoma, right breast cancer
โœ“ โœ“
2839079 44 F VA 04/30/2025 COVID19
 PFIZER\BIONTECH
 paa226428
Rash Rash
Patient reported full body rash within 24 hours of vaccine Patient reported full body rash within 24 hours of vaccine
2839080 18 F TX 04/30/2025 MNQ
MNQ
 NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
 amab030a
amab030a
Cold sweat, Lethargy, Presyncope, Somnolence, Tinnitus; Yawning Cold sweat, Lethargy, Presyncope, Somnolence, Tinnitus; Yawning
After vaccine was given, patient was alert and oriented. Patient stood up, walked out of vaccination... After vaccine was given, patient was alert and oriented. Patient stood up, walked out of vaccination room to lobby and sat down. Patient's mother came to get pharmacist to say patient almost fainted. Upon viewing patient, she exhibited signs of lethargy, cold clammy skin, continuous yawning, and difficulty keeping eyes open. Patient also stated she had constant ear ringing. Offered to call 911 and ambulance, but patient's mother declined and wanted to take patient to hospital herself. Helped patient walk to vehicle and watched as party left parking lot heading to hospital. Called for welfare check 2 days later but received no answer. Left voicemail for call back. More
2839081 69 F MI 04/30/2025 RSV
 PFIZER\WYETH
 HM9855
Extra dose administered, No adverse event Extra dose administered, No adverse event
No adverse event reported by patient. This reporting is due to finding that patient had previously ... No adverse event reported by patient. This reporting is due to finding that patient had previously received Arexvy RSV vaccine at another facility approx. 1 year prior (08/15/2023) More
2839082 57 M TX 04/30/2025 HEPAB
 GLAXOSMITHKLINE BIOLOGICALS
 344J3
Asthenia, Brain fog, Chills, Dizziness, Pyrexia Asthenia, Brain fog, Chills, Dizziness, Pyrexia
Fever, chills, dizziness, full body weakness, foggy thinking Fever, chills, dizziness, full body weakness, foggy thinking
2839086 17 F LA 04/30/2025 MENB
 NOVARTIS VACCINES AND DIAGNOSTICS
 77KA5
Injection site erythema Injection site erythema
2 x 3 area of erythema at injection site, mild swelling and tenderness, warm to touch. 2 x 3 area of erythema at injection site, mild swelling and tenderness, warm to touch.
2839087 0.42 M CA 04/30/2025 DTPPVHBHPB
RV5
 MSP VACCINE COMPANY
MERCK & CO. INC.
 U7623AA
Y014320
Injection site discolouration, Injection site erythema, Injection site induratio... Injection site discolouration, Injection site erythema, Injection site induration, Injection site mass, Injection site swelling; Injection site discolouration, Injection site erythema, Injection site induration, Injection site mass, Injection site swelling More
Day of vaccine: 2 hard knots under skin on LVL, swollen and red (mother has pics) Day 2: little bum... Day of vaccine: 2 hard knots under skin on LVL, swollen and red (mother has pics) Day 2: little bumps to the site (mother has pictures) One week after decreased but now has black spots. More
2839205 1 F NY 04/30/2025 MMRV
 MERCK & CO. INC.
 Y003882
Decreased appetite, Irritability, Malaise, Pyrexia, Rash morbilliform Decreased appetite, Irritability, Malaise, Pyrexia, Rash morbilliform
Developed Rubella Rash, Low Grade Fever, Malaise, Decrease Appetite, Fussy. Developed Rubella Rash, Low Grade Fever, Malaise, Decrease Appetite, Fussy.
2838406 4 M 04/29/2025 MMRV
MMRV
 MERCK & CO. INC.
MERCK & CO. INC.
 Y019173
Y019173
Erythema, Injection site erythema, Injection site pain, Pruritus, Rash; Rash ery... Erythema, Injection site erythema, Injection site pain, Pruritus, Rash; Rash erythematous, Rash papular More
raised, flat, red spots in a rash pattern on his abdomen; and his feet and hands were noticeably red... raised, flat, red spots in a rash pattern on his abdomen; and his feet and hands were noticeably red; injection site on the left arm was noticeably red and appeared tender; raised, flat, red spots in a rash pattern on his abdomen; Viral reaction; injection site on the left arm was noticeably red and appeared tender; itching on his hands and feet; This spontaneous report was received from a consumer or other non-health professional and refers to a 4-year-old male patient (reporter's son). The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Diphtheria vaccine toxoid;Pertussis vaccine acellular;Polio vaccine inact;Tetanus vaccine toxoid (Diphtheria vaccine toxoid;Pertussis vaccine acellular;Polio vaccine inact;Tetanus vaccine toxoid (DTAP/IPV) . On 31-Mar-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y019173, expiration date: 27-Jun-2024) 0.5 mL in left Arm, diluted with sterile diluent (MERCK STERILE DILUENT) (indication, expiration date, and lot # were not reported) for prophylaxis. On 02-Apr-2025 (also reported as this morning), the patient complained of itching on his hands and feet, and his feet and hands were noticeably red. The injection site on the left arm was noticeably red and appeared tender. He went to daycare as scheduled and was observed by his daycare teachers to behave normally all day, with continued reporting of his hands being itchy. Reporter reported these symptoms to his pediatric doctor, who advised her to keep an eye on it and schedule a follow up if we had concerns. In that evening reporter noted raised, flat, red spots in a rash pattern on his abdomen. The injection site on the left arm was more red and tender looking than in the morning. The rash did not seem to be making him uncomfortable, but she had a follow up virtual visit with his pediatrician to report the rash out of concern that it might be an allergic reaction to a vaccine component. The pediatrician advised that it did not appear to be an allergic reaction, but that it appeared to be a rash common with viral reactions. The pediatrician advised continued monitoring of the rash and to follow up if my son developed sores in or around his mouth or difficulty eating. At the reporting time, the outcome of the events was unknown. The causal relationship between all the events and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) was not provided. More
2838407 NY 04/29/2025 HEPA
 MERCK & CO. INC.
 X025482
Expired product administered, No adverse event Expired product administered, No adverse event
No additional adverse event; expired dose of VAQTA was administered to a patient; This spontaneous r... No additional adverse event; expired dose of VAQTA was administered to a patient; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 17-APR-2025, the patient was vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) first dose, (exact dose administered, anatomical route of administration were not reported) (lot #X025482, who had been verified to be a valid lot number and expiration date reported and validated as 12-APR-2025) as prophylaxis (expired product administered). No additional adverse event. More
2838408 17 F NV 04/29/2025 HPV9
 MERCK & CO. INC.
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
HCP called to report a female who received their first dose of GARDASIL 9 in August of 2024 at the a... HCP called to report a female who received their first dose of GARDASIL 9 in August of 2024 at the age of 17 has not received any subsequent doses since. No symptoms reported. Caller did not have any other information to provide at the time of the; No additional adverse event reported; This spontaneous report was received from a pharmacist and refers to a 17-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unspecified date in August 2024, the patient was vaccinated with first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL๏ฟฝ9), 0.5 mL (.5 ml), (lot # and expiration date were not reported) as prophylaxis, and had not received any subsequent doses since (inappropriate schedule of product administration). No additional adverse event. More
2838409 CT 04/29/2025 MMR
MMR
MMR
MMR
VARCEL
VARCEL
VARCEL
VARCEL
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.







Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps... Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive; Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive; Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive; Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive; Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive; Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive; Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive; Antibody test negative, Bone marrow transplant, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive More
No evidence of immunity to measles or varicella.; No evidence of immunity to measles or varicella.; ... No evidence of immunity to measles or varicella.; No evidence of immunity to measles or varicella.; Caller reported that patient had their bone marrow completely reconstituted during leukemia treatment resulting in lack of immunity. / boosters of VARIVAX in 2013 and MMR-II in 2015 following leukemia treatments.; This spontaneous report was received from a physician, regarding a 17-year-old patient of unknown gender. The patient's medical history and concomitant medication were not reported. Concurrent conditions included Leukemia (in remission). On 2008, the patient was vaccinated with a dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), at a dose of 0.5 mL as prophylaxis in combination with sterile diluent. And also on the same year, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), also at a dose of 0.5 ml as prophylaxis in combination with sterile diluent (strengths, doses, schemes, routes and anatomical locations of administration, lot numbers and expiration dates were not reported). Then on 2013, the patient received a booster of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) and on 2015 a booster of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), this following leukemia treatment. On an unspecified date, they ran titers on the patient for measles, mumps, rubella, and varicella. There was evidence of immunity to mumps and rubella, but no evidence of immunity to measles or varicella. Caller reported that patient had their bone marrow completely reconstituted during leukemia treatment resulting in lack of immunity. The outcome of the events was not provided. No symptoms reported. The causal relationship between the events and suspect vaccines was not provided. More
2838410 04/29/2025 VARZOS
 UNKNOWN MANUFACTURER
 UNK
Herpes zoster, Vaccination failure Herpes zoster, Vaccination failure
Suspected vaccination failure; I got the vaccine honey but I still got them; This serious case was r... Suspected vaccination failure; I got the vaccine honey but I still got them; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I got the vaccine honey but I still got them). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 22-APR-2025 This case was reported by a patient via interactive digital media. The patient got the vaccine honey but still got them. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine. More
2838419 15 M MP 04/29/2025 COVID19
HPV9
 PFIZER\BIONTECH
MERCK & CO. INC.
 LN0590
Y008119
Urticaria; Urticaria Urticaria; Urticaria
Patient developed diffuse hives shortly after receiving the COVID and HPV vaccine. I saw him the mor... Patient developed diffuse hives shortly after receiving the COVID and HPV vaccine. I saw him the morning after injaction adn the hives have persisted. No other symptoms. Patient was diagnosed with atypical pneumonia at the visit he received the vaccines and was prescribed azithromycin. He had not yet taken the medication when the rash arose More
2838420 0.5 F GA 04/29/2025 DTAPHEPBIP
HIBV
PNC15
RV5
 GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR
MERCK & CO. INC.
MERCK & CO. INC.



Infant irritability, Pyrexia; Infant irritability, Pyrexia; Infant irritability,... Infant irritability, Pyrexia; Infant irritability, Pyrexia; Infant irritability, Pyrexia; Infant irritability, Pyrexia More
High fever 4 hours after receiving vaccines at 6 mo. well visit. Fever of 103 and extreme fuzziness ... High fever 4 hours after receiving vaccines at 6 mo. well visit. Fever of 103 and extreme fuzziness for greater than 3 hours. More
2838421 64 M CA 04/29/2025 COVID19
 PFIZER\BIONTECH
 hn0477
Arthritis, Contusion, Pain in extremity Arthritis, Contusion, Pain in extremity
pt complains of arm pain. Patient returned a year later after vaccine was administered. Upon checkin... pt complains of arm pain. Patient returned a year later after vaccine was administered. Upon checking with patient's physician, physician stated pt has a severe arthritis. Also, noted at the time of reporting, pt had a greenish blue bruise. More
2838466 13 F TN 04/29/2025 MMR
 MERCK & CO. INC.
 y018703
Dizziness, Fall Dizziness, Fall
Patient was in the vaccine room with her mother and two younger sisters who were both getting the sa... Patient was in the vaccine room with her mother and two younger sisters who were both getting the same vaccination. Patient seemed to be fine after I injected the vaccine. She then swapped a seat with her younger sister so the sister can vaccinated. The patient was watching me give the vaccine when she got lightheaded, dizzy and fell from the chair on the ground. I advised the mom to keep her hand under the patient's head. I monitored the patient for any allergic reaction and loss of consciousness while the store manager on duty called EMS. EMS took over from their and monitored the patient. After about 30minutes EMS team asked the parents if they want to take their daughter to the ER. Parents declined and said they will monitor her at home. The patient came back to the pharmacy with her dad the next night and seemed to be doing well. More
2838467 60 F MI 04/29/2025 MMR
PNC20
VARZOS
 MERCK & CO. INC.
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
 X026328
LC5484
ME424
Wrong product administered; Wrong product administered; Wrong product administer... Wrong product administered; Wrong product administered; Wrong product administered More
The patient was given the Shingrix vaccine instead of the MMR vaccine. After being notified of the m... The patient was given the Shingrix vaccine instead of the MMR vaccine. After being notified of the mistake, she returned to the clinic and received the MMR vaccine. More
2838468 13 F MI 04/29/2025 HPV9
 MERCK & CO. INC.
Joint stiffness, Mobility decreased, Pain, X-ray Joint stiffness, Mobility decreased, Pain, X-ray
Stiffness in joint. Loss of mobility and extreme prolonged pain going well beyond normal timeframe. Stiffness in joint. Loss of mobility and extreme prolonged pain going well beyond normal timeframe.
2838469 0.17 M 04/29/2025 DTAPHEPBIP
 GLAXOSMITHKLINE BIOLOGICALS
 B532G
No adverse event, Wrong product administered No adverse event, Wrong product administered
DTap, Hep B, Polio combination (Pediarix) given incorrectly in place of single DTaP. No treatment g... DTap, Hep B, Polio combination (Pediarix) given incorrectly in place of single DTaP. No treatment given. Per conversation with client's mother on 4/28/25, child had no symptoms/signs of adverse reaction post vaccination. More
2838470 33 F TN 04/29/2025 YF
YF
YF
YF
YF
YF
 SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
SANOFI PASTEUR
 UK133AB
UK133AB
UK133AB
UK133AB
UK133AB
UK133AB
Chills, Cough, Dyspnoea, Headache, Vomiting; Asthma, Chills, Condition aggravate... Chills, Cough, Dyspnoea, Headache, Vomiting; Asthma, Chills, Condition aggravated, Cough, Dyspnoea; Headache, Vomiting; Chills, Cough, Dyspnoea, Headache, Vomiting; Asthma, Chills, Condition aggravated, Cough, Dyspnoea; Headache, Vomiting More
Pt started having shortness of breath and coughing a few hours after receiving the vaccine a rescue ... Pt started having shortness of breath and coughing a few hours after receiving the vaccine a rescue inhaler has been ineffective. Pt had one episode of vomiting the next day. Mild chills and intermittent headache noted. More
2838471 67 F NC 04/29/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Injection site erythema, Injection site induration, Injection site pain, Injecti... Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth More
pt states that the same day the injection site became the size of a quarter then it kept growing. Af... pt states that the same day the injection site became the size of a quarter then it kept growing. After about 3 weeks it was about 4" x 3" in size. It was red, hot hard and very painful. She contacted the pharmacy and was told to report it. It took about 4 months for it to completely disappear. She will contact her PCP about getting getting second dose. More
2838472 46 F IA 04/29/2025 HPV9
MMR
 MERCK & CO. INC.
MERCK & CO. INC.
 Y012864
222H3
No adverse event, Product administered to patient of inappropriate age; No adver... No adverse event, Product administered to patient of inappropriate age; No adverse event, Product administered to patient of inappropriate age More
Patient was too old to receive HPV vaccine; no adverse events reported or noted. Patient was too old to receive HPV vaccine; no adverse events reported or noted.
2838473 50 M IA 04/29/2025 HPV9
MMR
 MERCK & CO. INC.
MERCK & CO. INC.
 Y012864
222H3
No adverse event, Product administered to patient of inappropriate age; No adver... No adverse event, Product administered to patient of inappropriate age; No adverse event, Product administered to patient of inappropriate age More
patient was over the recommended age limit for HPV vaccine; no adverse events reported or noted patient was over the recommended age limit for HPV vaccine; no adverse events reported or noted
2838474 46 M IA 04/29/2025 HPV9
MMR
 MERCK & CO. INC.
MERCK & CO. INC.
 Y012864
222H3
No adverse event, Product administered to patient of inappropriate age; No adver... No adverse event, Product administered to patient of inappropriate age; No adverse event, Product administered to patient of inappropriate age More
Patient was over the recommended age for HPV vaccine; no adverse events reported or noted. Patient was over the recommended age for HPV vaccine; no adverse events reported or noted.
2838475 1.17 M KY 04/29/2025 MMR
 MERCK & CO. INC.
 X011431
Unevaluable event Unevaluable event
none none
2838476 40 F NJ 04/29/2025 TDAP
 SANOFI PASTEUR
Wrong product administered Wrong product administered
I was told I was being given a tetanus shot it was not explained to me they were giving me the combi... I was told I was being given a tetanus shot it was not explained to me they were giving me the combination shot that included pertussis. I have never received the pertussis vaccination and even had a note in my file as a child that said I needed to be kept home if there was an outbreak of whooping cough. I did not consent to receiving the TDAP vaccination and would not have consented to receiving it. If they did not have the Td vaccine in the hospital I would have completely declined the vaccine as what caused my wound does not have a high risk for tetanus. I realized I was given the incorrect vaccine about 7 hours after when I was reading my discharge papers, I contacted the hospital who said they would do their own investigation to find out why I was not told what medication I was being given but of course there is no way to take back the vaccine. More
2838477 29 F TN 04/29/2025 HPV9
 MERCK & CO. INC.
 y012921
Injection site pain Injection site pain
pain and soreness at injection site continues 26 days after administration pain and soreness at injection site continues 26 days after administration
2838479 20 F PA 04/29/2025 HEPA
 GLAXOSMITHKLINE BIOLOGICALS
 4T93R
Hypotension, Muscle tightness, Seizure like phenomena, Syncope, Unresponsive to ... Hypotension, Muscle tightness, Seizure like phenomena, Syncope, Unresponsive to stimuli More
Patient reported prior to receiving the vaccine that she has fainted before/during vaccines. Vaccine... Patient reported prior to receiving the vaccine that she has fainted before/during vaccines. Vaccine was administered around 11:10am. After the vaccine was administered, within a minute (11:12am) she started to faint/appeared to almost be seizing rather than a full dead-weight drop (tensed up in the arms of the pharmacist/technican attending to her). The patient was shaken in an attempt to wake her, however, she was not responsive. When she came to she stated she was "okay" but continued to fade in and out. She was laid on the floor as to follow vaccine training until paramedics arrived. Paramedics arrived by 11: 25am and checked her vitals. They found her blood pressure was low (unknown specific value) and took her on the stretcher to ensure that she would get the proper approval that she is okay. Further reactions unknown. More
2838480 64 F NJ 04/29/2025 MMR
MMR
 MERCK & CO. INC.
MERCK & CO. INC.
 Y010372
Y010372
Dizziness, Ear pain, Feeling abnormal, Headache, Pruritus; Rhinorrhoea, Vulvovag... Dizziness, Ear pain, Feeling abnormal, Headache, Pruritus; Rhinorrhoea, Vulvovaginal pruritus More
Patient received the vaccination on 4/28/25 at 4:00PM. After receiving MMR vaccination dose number... Patient received the vaccination on 4/28/25 at 4:00PM. After receiving MMR vaccination dose number 1. about 5 minutes afterwards she stated, " I don't feel right ". She then stated, " I feel fuzzy in the head". I assisted her to the exam table and laid her in supine position. Vitals taken every 5 minutes were stable and consistent with no fluctuations present. No visible rashes present on body or chest. Reported no shortness of breath, chest pain, difficulty breathing, nausea, or vomiting. NO swelling of face, lips or tongue noted. She reported that she was feeling better and wanted to drive home. She called the following day on 4/29/25 at 8:30AM and stated she had to go to the emergency room last night at 10:00PM because she was having chest tightness and feeling short of breath. She also reported severe headache, left ear pain and itchiness in the right ear and runny nose. States after receiving steroid injection in the ER she felt itchiness in the vaginal area and rectum. She was reportedly seen in the emergency room prescribed steroids and was sent home afterwards and reported she was feeling better. She states she is still experiencing mild headaches and feeling dizzy. She was advised by our provider to follow up with her PCP and if it persists return to the emergency room More
2838481 20 M WA 04/29/2025 FLU3
HEP
TDAP
 SANOFI PASTEUR
DYNAVAX TECHNOLOGIES CORPORATION
GLAXOSMITHKLINE BIOLOGICALS
 UT8434JA
945665
L5229
Loss of consciousness, Pallor; Loss of consciousness, Pallor; Loss of consciousn... Loss of consciousness, Pallor; Loss of consciousness, Pallor; Loss of consciousness, Pallor More
Patient denied having syncope in the past. No records of vaccinations, in state database nor that pa... Patient denied having syncope in the past. No records of vaccinations, in state database nor that patient brought. Flu, Tdap and Heplisav-B #1 vaccines administered. Tolerated well despite anxiety with needles. After administering the vaccines, venous blood collection began. During blood collection, patient passed out as 1st (of 2 vials were being collected). Right before he passed out, stated, "I feel like I'm going to pass out." Then immediately his skin turned pale and started sliding down out of the phlebotomy chair. Needle taken out safely after tourniquet was removed. Ensured patient was safe and did not slide out of chair while calling for more assistance. 1 more RN and 1 MA arrived. Ammonia towelette used on patient who continued to slide out of chair, so he was lowered to the ground in a sitting position against the chair/cabinet, and his body convulsed a couple of times. We supported his head so it didn't hit against the cabinet/chair. Within 20-30 seconds, patient regained consciousness. Patient states he did not eat yet that day. Patient was assisted to lie down on yoga mat. Color gradually came back and then pale again with repeated bouts of nausea. Emesis x3-5 after attempting to drink some water and eating 1 graham cracker. Patient stayed in employee health clinic until his Grandma was able to come get him roughly 40 min. after he contacted her to pick him up. Patient was assisted to Grandma's suv by MA and RN who administered the vaccines and was doing the blood draw. Wheelchair was used to safely bring patient to Grandma's suv. Instructed Grandma to seek medical care/call 911 if needed if patient's nausea didn't improve and he was still light headed. The following day (4/23,) patient was "almost back to 100% with a tiny bit of nausea." Patient reports being able to keep food down since the night before (4/22). More
2838482 83 F WA 04/29/2025 COVID19
COVID19
 MODERNA
MODERNA
 8080803
8080803
Fall, Fatigue, Feeling jittery, Head injury, Injection site erythema; Joint inju... Fall, Fatigue, Feeling jittery, Head injury, Injection site erythema; Joint injury More
She noticed her arm was red from the injection site almost to her elbow (COVID Arm). She is very tir... She noticed her arm was red from the injection site almost to her elbow (COVID Arm). She is very tired. She felt jittery on the inside. On 4/25/25 Patient fell in the early AM hit her head and knee (not sure if this is related to her vaccine). More
2838483 0.83 M VA 04/29/2025 DTAPIPV
 GLAXOSMITHKLINE BIOLOGICALS
 5G23D
Wrong product administered Wrong product administered
Incorrect Vaccine administered. Treatment: Tylenol Incorrect Vaccine administered. Treatment: Tylenol
2838484 28 F NY 04/29/2025 TYP
 BERNA BIOTECH, LTD.
 3004089
Disturbance in attention, Vision blurred Disturbance in attention, Vision blurred
Client called office after taking 1 dose of oral typhoid complaining of blurry vision and inability ... Client called office after taking 1 dose of oral typhoid complaining of blurry vision and inability to stay focused. Client advised to stop medication and to seek out medical treatment from PCP or ER More
2838485 23 M NJ 04/29/2025 HEP
 GLAXOSMITHKLINE BIOLOGICALS
 GC3NH
Underdose Underdose
Ped dose instead of adult dose Ped dose instead of adult dose
2838486 27 M NJ 04/29/2025 HEP
 GLAXOSMITHKLINE BIOLOGICALS
 GC3NH
Underdose Underdose
Ped dose instead of adult dose Ped dose instead of adult dose
2838487 16 F NM 04/29/2025 MNQ
 SANOFI PASTEUR
 U8494AA
Fatigue, Headache, Malaise, Oropharyngeal pain, Sneezing Fatigue, Headache, Malaise, Oropharyngeal pain, Sneezing
mom called the day after and said that pt got "very sick", she started with sneezing, sore... mom called the day after and said that pt got "very sick", she started with sneezing, sore throat, having a headache and feeling tired about 4-5 hours after vaccine injection. No reaction site pain. no lethargy. no difficulty breathing More
2838488 11 F NM 04/29/2025 HPV9
MNQ
TDAP
 MERCK & CO. INC.
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
 Y008119
U8494AA
4K7JP
Cough, Headache; Cough, Headache; Cough, Headache Cough, Headache; Cough, Headache; Cough, Headache
Pt was already reporting a slight cough, thought to be related to allergies. The next day after inje... Pt was already reporting a slight cough, thought to be related to allergies. The next day after injection, the mom called our clinic and was worried that pt was coughing and having a headache. No injection site reaction. no severe difficulty breathing. More
2838489 8 M ID 04/29/2025 COVID19
 PFIZER\BIONTECH
 LM2045
Product storage error Product storage error
Vaccine stored inappropriately Vaccine stored inappropriately
2838490 19 F MI 04/29/2025 MMRV
 MERCK & CO. INC.
 y008283
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
This was an administration error. The patient was given MMRV and this vaccine is suppose to be give... This was an administration error. The patient was given MMRV and this vaccine is suppose to be given from 12 months of age to 12 years. Patient did not experience any adverse events. More
๐Ÿ“‹ Privacy Policy & Data Disclaimer